title: Detection of antibodies against domain 1 of β2-glycoprotein I is key in predicting thromboembolic complications in patients with systemic lupus erythematosus.
authors.affiliation: Department of Laboratory Science, Faculty of Health Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan. Electronic address: nojima-j@yamaguchi-u.ac.jp.
authors.forename: Junzo
authors.initials: J
authors.lastname: Nojima
authors.affiliation: Department of Laboratory Science, Faculty of Health Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
authors.forename: Yukari
authors.initials: Y
authors.lastname: Motoki
authors.affiliation: Department of Laboratory Science, Faculty of Health Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
authors.forename: Kazusa
authors.initials: K
authors.lastname: Hara
authors.affiliation: IL Japan Co., Ltd., Mita-Kanda Bldg., 1-3-30 Mita, Minato-ku, Tokyo 108-0073, Japan.
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Sakata
authors.affiliation: Department of Laboratory Science, Faculty of Health Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
authors.forename: Hidehiro
authors.initials: H
authors.lastname: Tsuneoka
authors.affiliation: Department of Laboratory Science, Faculty of Health Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Ichihara
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017152:Antibodies, Antiphospholipid / Q000378:metabolism*; D002648:Child; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D013923:Thromboembolism / Q000097:blood* / Q000150:complications; D055815:Young Adult; D053482:beta 2-Glycoprotein I / Q000378:metabolism*
chemical_list: D017152:Antibodies, Antiphospholipid; D053482:beta 2-Glycoprotein I
keywords: Anti-phospholipid antibodies; Systemic lupus erythematosus; Thromboembolic complications; β2-Glycoprotein I